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Abstract
The mission of the Armed Forces Health Surveillance Center, Division of Global Emerging Infections Surveillance
and Response System (AFHSC-GEIS) is to support global public health and to counter infectious disease threats to
the United States Armed Forces, including newly identified agents or those increasing in incidence. Enteric diseases
are a growing threat to U.S. forces, which must be ready to deploy to austere environments where the risk of
exposure to enteropathogens may be significant and where routine prevention efforts may be impractical. In this
report, the authors review the recent activities of AFHSC-GEIS partner laboratories in regards to enteric disease
surveillance, prevention and response. Each partner identified recent accomplishments, including support for
regional networks. AFHSC/GEIS partners also completed a Strengths, Weaknesses, Opportunities and Threats (SWOT)
survey as part of a landscape analysis of global enteric surveillance efforts. The current strengths of this network
include excellent laboratory infrastructure, equipment and personnel that provide the opportunity for high-quality
epidemiological studies and test platforms for point-of-care diagnostics. Weaknesses include inconsistent guidance
and a splintered reporting system that hampers the comparison of data across regions or longitudinally. The newly
chartered Enterics Surveillance Steering Committee (ESSC) is intended to provide clear mission guidance, a
structured project review process, and central data management and analysis in support of rationally directed
enteric disease surveillance efforts.
Background
Enteric infections pose a significant risk to the 80 to
100 million travelers from industrialized countries visiting
developing countries [1] and are leading causes of death
among children in these same developing countries, where
they claimed between 1.4 and 2.5 million lives in the year
2000 [2]. From the perspective of the United States
Department of Defense (DoD), political instabilities in
many parts of the world require that U.S. military person-
nel must be ready to deploy to austere environments
where the risk of exposure to infectious diseases may be
significant and where routine preventive health efforts are
often impractical. Acute diarrheal illness has played a sig-
nificant role in the outcomes of military campaigns
throughout history [3-5]. Advances in environmental
health interventions and effective therapies have been
insufficient to eliminate the burden of enteric infections in
deployed military personnel, which can result in lost work
days, increased health care utilization, and compromised
operational readiness and effectiveness [5-9].
For these reasons, enteric disease surveillance was estab-
lished as a pillar within the AFHSC-GEIS system. This sys-
tem is intended to unite the resources of DoD research
facilities and the military health system to facilitate the
rapid recognition and understanding of, and response to,
infectious disease threats to protect global health and that
of the U.S. forces. Herein, the authors report on past and
current accomplishments of enteric surveillance efforts
within AFHSC-GEIS, provide an assessment of how these
efforts fit within a changing landscape of global enteric
disease research efforts, and discuss future efforts to
improve coordinated efforts within the program.
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AFHSC-GEIS currently supports enteric surveillance
activities at the five overseas DoD research laboratories
and at the Naval Environmental and Preventive Medi-
cine Unit Two (NEPMU-2) in Norfolk, Va. The reach of
these laboratories extends beyond their respective host
countries, as each institution has its own network of
regional activities, working with neighboring countries
as well as their primary host. Table 1 lists some of the
accomplishments of the laboratories participating in the
AFHSC-GEIS network, including training host nation
personnel, providing reference laboratory capabilities
and investigating outbreaks. The following vignettes
describe representative efforts within this surveillance
network, selected based on their diversity and impact.
Pediatric case-control study—Armed Forces
Research Institute of Medical Sciences (AFRIMS),
Bangkok, Thailand
AFRIMS was established over 40 years ago as a tropical
disease research and development institution within
DoD. The Department of Enteric Diseases at AFRIMS
has a sustained history of conducting collaborative
research, epidemiology, and preclinical and clinical trials
on enteric diseases. In addition to supporting enteric
surveillance among U.S. troops deploying on military
training operations such as Cobra Gold 2009 (Thailand)
and Balakatan 2009 (Philippines), AFRIMS, through
AFHSC-GEIS support, has continued a project of defin-
ing the etiologies of pediatric acute gastroenteritis and
antimicrobial resistance patterns among host country
populations in South Asia (Nepal) and Southeast Asia
(Thailand). Under these surveillance projects, over 2,500
cases and controls were enrolled during the past year.
This study has continued to demonstrate the impor-
tance of particular bacterial and viral pathogens in these
regions and the levels of antimicrobial resistance among
the most common bacterial etiologies—providing critical
information for treatment consideration in individuals
deploying to these regions (e.g., use of azithromycin for
empiric therapy among travelers/deployments to South-
east Asia).
Table 1 Recent Accomplishments of DoD Laboratory Partners in Enteric Disease Surveillance Under AFHSC-GEIS
Partner Clinical Surveillance and Capacity Building Laboratory Results/Accomplishments
AFRIMS ￿ Pediatric case-control study
￿ Enteric surveillance in troops deploying to Cobra Gold 2009
(Thailand) and Balaktan 2009 (Philippines)
￿ Defining etiology of AGE and antimicrobial resistance among
indigenous populations in South Asia and Southeast Asia
￿ Sites in Nepal and Thailand have enrolled more than 2500
cases and controls during the past year
￿ High rates of fluroquinolone and TMP-SMX resistance
among pediatric and travel-associated Campylobacter isolates.
￿ Most Shigella species are TMP-SMX resistant
NAMRU-3 ￿ Birth cohort research and epidemiology
￿ Severe diarrhea study at Cairo University
￿ Case-control study of modifiable risk behaviors
￿ Molecular biology and cholera/rotavirus microbiology reference
center for the Middle East and Africa
￿ Training workshops and courses for laboratorians from Afghanistan,
Djibouti, Ghana, Iraq, Jordan, Libya, Morocco, Sudan
￿ Biennial enteric disease surveillance in Operation Bright Star (Egypt)
￿ 2223 children enrolled to describe pathogen distribution
(2000 to 2005)
￿ 117 cases and 1:1 age-matched controls assessed for risk
behaviors including food and water sources
￿ 303 V. cholerae isolates archived and characterized—2
serotypes with widespread antimicrobial resistance
￿ 937 stool samples processed from eight countries to date
this year in capacity as WHO Rotavirus Reference Laboratory
￿ Norovirus outbreak response support, Incirlik Air Base,
Turkey
NMRCD-Peru ￿ Cohort study among basic combat trainees
￿ Antimicrobial surveillance testing in Lima and five departments of
Peru
￿ Received 2159 specimens for antimicrobial surveillance and
confirmed bacterial pathogens in 83 percent of them.
￿ The cohort study enrolled 381 participants with 84 diarrheal
cases with bacterial pathogens confirmed in 42 (50 percent).
NAMRU-2 ￿ 12,000 specimens from Indonesian pediatric diarrhea
￿ Surveillance project covered six cities on five islands and identified
rotavirus as the leading causative agent
￿ Advanced characterization of Campylobacter spp. and
Shigella spp.
USAMRU-K ￿ Movement of Enteric Microbiology Laboratory from Nairobi to
Kericho includes all ages case-control protocol at Kericho District
Hospital and two additional district hospitals in Kisumu
￿ Detected and identified bacterial pathogens in 28 percent
of diarrheal stool specimens
￿ Renovated infrastructure to enable facility relocation to the
new Microbiology Hub in Kericho (MHK)
￿ Five-year surveillance protocol uses case-control approach,
broadens testing spectrum, and includes antibiotic
susceptibility testing
￿ Clinical and (FDA-approved) molecular epidemiology of
diarrheal illnesses
NEPMU-2 ￿ Establishing diagnostic capability for Norovirus VGE collection kits
with thermal shipping boxes deployed to 30 ships
￿ Expected to start processing kits in early 2010
Acronyms: Acute gastroenteritis (AGE), Food and Drug Administration (FDA), trimethoprim-sulfamethoxazole (TMP-SMX), viral gastroenteritis (VGE), World Health
Organization (WHO).
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regional cholera Network—Naval Medical
Research Unit no. three (NAMRU-3), Cairo, Egypt
Over the past decade, NAMRU-3 has served as a core
laboratory for enteric disease research and epidemiology
in pediatric populations through a series of birth cohorts
[10-13] and other surveillance studies and clinical trials
conducted among U.S. military populations deployed to
Egypt and the surrounding region [6-8,14-24]. This
track record in enteric disease surveillance and research,
modern laboratory and experienced staff has positioned
NAMRU-3 as a hub for enteric surveillance activities in
the region. In the past year, AFHSC-GEIS has supported
pediatric hospital studies at Cairo University, where 140
participants with severe diarrhea have been enrolled in
the last year. NAMRU-3 and AFHSC-GEIS, in colla-
boration with two Egyptian university medical centers,
have also initiated a case-control study looking at modi-
fiable risk factors where a total of 164 cases and controls
have been enrolled to date. These projects will provide
important data about pathogen distribution, and the epi-
demiological, clinical, economic and molecular charac-
teristics of diarrhea in Egypt. They will also provide the
opportunity to explore novel pathogen discovery.
NAMRU-3 has established a Vibrio cholerae micro-
biology and molecular biology reference center for
Africa and the Middle East and serves as a reference
laboratory for rotavirus characterization in partnership
with the World Health Organization (WHO) in an effort
to understand and identify the emergence of novel viral
strains under vaccine pressure in the region. Both pro-
jects have established links with researchers and govern-
mental organizations in countries affected by cholera
and rotavirus, and worked to characterize the isolates
while providing training opportunities for the host
country’s public health community. To date, this initia-
tive has established 16 active sites, trained over 53 peo-
ple, and collected and tested 1,257 specimens. The
establishment of this reference center activity is an
example of how regional laboratories can serve an
important global health surveillance function and build
capacity and capability in developing countries.
Enteric disease surveillance among Peruvian
Military Recruits—Naval Medical Research Center
Detachment (NMRCD), Lima, Peru
NMRCD was established in 1983 as a joint enterprise of
the U.S. Navy and the Peruvian Navy with a mission to
conduct research on infectious diseases of military and
public health importance in Peru and Latin America.
AFHSC/GEIS supports enteric disease research at
NMRCD through funding of prospective military
cohorts, antimicrobial resistance surveillance in enteric
pathogens and a passive surveillance network for febrile
diseases including diarrhea.
In collaboration with the Peruvian Army, NMRCD has
conducted a prospective cohort of diarrheal disease inci-
dence and prevalence among Peruvian soldiers in the
Peruvian Amazon. To date, over 2,900 participants have
enrolled in the cohort alone. Baseline stool and serum
specimens are obtained from participants, and active
surveillance is conducted to detect and evaluate cases of
acute diarrhea. Fecal specimens are tested by means of
conventional culture, by PCR-based methods for the
detection of diarrheagenic Escherichia coli (DEC), and
by microscopy and ELISA for parasitic pathogens.
Ongoing results at Vargas Guerra show an annual inci-
dence of diarrhea from 0.31-0.70 episodes of diarrhea per
person-year since the project began in 2003. Prior to the
establishment of active surveillance at the study site in
2004, 40 percent of diarrhea cases presenting for medical
care were confirmed as Shigella (primarily S. flexneri 2a
and 3a) by culture [25]. With active case finding, an
increased number of less-severe cases were identified,
with the proportion of shigellosis as a cause of diarrhea
decreasing to a lower but still significant 24 percent of
cases. S. flexneri is a pathogen of major military and pub-
lic health importance and is the target of vaccine devel-
opment by the Walter Reed Army Institute of Research
(WRAIR) and the Military Infectious Diseases Research
Program (MIDRP). NMRCD also conducts antimicrobial
drug resistance surveillance for enteric pathogens in Peru
w i t hs u p p o r tf r o mA F H S C - G E I S .L a s ty e a r ,N M R C D
obtained 2,159 isolates from collaborating project sites in
five departments of Peru with differing climates and
population densities. From the isolates, 1,802 bacterial
pathogens were confirmed. Of these 1,802 specimens,
47.8 percent were confirmed as Shigella spp., 5.4 percent
as Salmonella spp., 35.7 percent as Campylobacter spp.,
and 6.7 percent as diarrheagenic E. coli (DEC). Among
organisms evaluated, Campylobacter spp. showed high
rates of resistance to fluoroquinolones (91.6 percent),
although local rates of fluoroquinolone resistance were
much lower in the Amazon basin (28 percent). Overall
rates of macrolide resistance were low for Campylobacter
spp. (azithromycin 1.9 percent, erythromycin 3.0 per-
cent). Shigella strains were broadly resistant to trimetho-
prim-sulfamethoxazole (88.3 percent), with lower but
noteworthy resistance rates to that agent noted in salmo-
nellae (19.4 percent). Salmonella spp. was generally resis-
tant to erythromycin (90.8 percent) but susceptible to
fluoroquinolones (1.0 percent resistant to ciprofloxacin)
and azithromycin (7.1 percent resistant). DEC had
broadly preserved quinolone susceptibility, with only one
EPEC isolate out of 120 DEC noted to be resistant to
ciprofloxacin.
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zation of antimicrobial resistance mechanisms in enteric
pathogens from Peruvian children with diarrhea, in col-
laboration with colleagues at the Universidad Peruana
Cayetano Heredia and the Instituto de Investigación
Nutricional (both in Lima). Specific activities include the
detection of efflux pumps and other fluoroquinolone
resistance mechanisms in DEC, and the identification of
extended-spectrum beta-lactamases in DEC.
Advanced characterization of enteric pathogens
in Indonesian children—Naval Medical Research
Unit no. two (NAMRU-2), Jakarta, Indonesia
NAMRU-2 conducts disease surveillance, research, out-
break response, capacity building and training through-
out Southeast Asia, including in Cambodia, Indonesia
and the Lao People’s Democratic Republic. NAMRU-2
contributed to the identification of the first case of rota-
virus strain G12 in Indonesia, an important finding for
emerging pathogen surveillance [26]. The combination
of the P [6] genotype in this rotavirus strain leads to the
potential of zoonotic transmission and is important for
vaccine development and identification of novel and
emerging rotavirus strains. In addition, capitalizing on
over 12,000 specimens collected from an Indonesian
pediatric diarrhea surveillance effort, NAMRU-2 investi-
gators evaluated the molecular epidemiology and antimi-
crobial resistance patterns of a number of important
bacterial pathogens in this region, better informing
empiric treatment strategies for travelers to these
regions. One of the most common bacterial genera,
Campylobacter, was identified in over 300 cases of chil-
dren presenting with diarrhea. Antimicrobial susceptibil-
ity testing to C. jejuni identified increasing levels
of resistance to ciprofloxacin between 2005 and 2008
(21 percent to 65 percent) as well as a moderate level of
m a c r o l i d er e s i s t a n c ea m o n gS. flexneri and S. sonnei
isolates (M. Kasper, personal communication). The
molecular mechanism of ciprofloxacin resistance in
Campylobacter spp. was studied using a real-time PCR
assay to discriminate between wild-type and mutant
alleles that can confer resistance to fluoroquinolones.
Establishment of an enterics microbiology
laboratory—U.S. Army Medical Research Unit,
Kenya (USAMRU-K), Kericho, Kenya
A consortium of several regional laboratories conducting
infectious disease surveillance and research, USAMRU-K
recently moved its principal Enteric Microbiology Labora-
tory from the Nairobi campus to Kericho, designated the
Microbiology Hub in Kericho (or “MHK”). This laboratory
includes automated bacterial identification and susceptibil-
ity testing, rotavirus enzyme immunoassay (EIA), and lim-
ited parasite EIA testing. The MHK has 9,200 square feet
of laboratory space with the capacity to process over 100
stool specimens per week and an enhanced molecular epi-
demiology focus on enteric microorganisms. Ongoing
expansion at MHK will provide the capacity to perform
important regional epidemiology and clinical trials related
to enteric and other bacterial diseases. In addition to sup-
porting clinical microbiology services at Kericho District
Hospital, a new protocol was implemented in September
2009 to conduct a case-control study among local residents
presenting to Kericho and Kisumu District Hospitals with
diarrhea. This project will be expanded with funding from
military research programs to support the development of
potential field sites for enteric vaccine studies and to con-
duct observational and clinical trials in military and similar
traveler populations throughout the region.
Establishment of a norovirus reference laboratory
to support shipboard and recruit population
surveillance—Naval Environmental and
Preventive Medicine Unit no. 2 (NEPMU-2),
Norfolk, VA
Outbreaks of acute viral gastroenteritis, particularly nor-
ovirus, among U.S. military deployed forces, as well as
recruit and training populations, are a potential threat
to mission capacity and operational readiness, though
complete epidemiologic information on the frequency
and magnitude of these outbreaks is lacking [5,27-34].
A study by Baily et al. reported that outbreaks of acute
gastroenteritis were frequent among U.S. and British
forces deployed to Iraq and Afghanistan from 2002 to
2007, and of 11 identified outbreaks, 10 had a proven
viral cause [35]. Of 84 viral pathogens identified in this
series, nearly three-quarters were norovirus. Despite the
accumulation of disease threat data, DoD lacks diagnos-
tic capacity under current shore-based and fleet plat-
forms. To remedy this fact, NEPMU-2 is establishing a
diagnostic capability for norovirus by developing its
laboratory and establishing prospective detection and
response activities with recruit training centers,
deployed forces and Navy vessels. Collaborative partner-
ships with the NEPMUs in San Diego and Hawaii have
also been developed to enable future surveillance world-
wide. Further, the first viral gastroenteritis collection
kits containing outbreak guidance, basic epidemiologic
collection materials, viral transport media (VTM) sup-
plies, and a thermal shipping box have been deployed
for an initial distribution to 30 ships. Data collection for
outbreaks during 2010 is anticipated.
Landscape analysis
AFHSC-GEIS in the context of global enteric disease
surveillance efforts
A growing number of scientific and non-governmental
organizations outside the military are showing a growing
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organized surveillance activities being established
among widespread populations in the developing world
(Table 2). These activities include disease-focused net-
works, such as the WHO-supported regional Rotavirus
Surveillance Networks (RSN) [36-38] and the recently
established CHOLDInet for cholera and other causes of
diarrheal diseases [39]. Under the CDC Global Disease
Detection Program, several International Emerging
Infections Program (IEIP) sites have been established
throughout Africa, Asia and Central America. These
programs conduct population-based surveillance to
track diseases of global public health importance,
including diarrhea.
Two additional research efforts—the Global Enteric
Multi-Center Surveillance (GEMS) study and the Net-
work for the Study of Malnutrition and Enteric Diseases
(MAL-ED)—are designed to provide data needed to
guide the development and implementation of enteric
vaccines and other public health interventions to reduce
the morbidity and mortality of diarrheal diseases, as well
as to study the relationships between malnutrition and
enteric infections.
Beyond the focus on specific diseases and pediatric
populations of the developing world, other surveillance
activities focus on acute enteric infections within the
United States. These include the Foodborne Diseases
Active Surveillance Network (FoodNet) [40] and the
National Antimicrobial Resistance Monitoring System
(NARMS). The GeoSentinel Network (GSN), established
in 1995 by the International Society of Travel Medicine
(ISTM) and the CDC, is a worldwide communication
and data collection network for the study of travel-
related morbidity conducted through participating travel
clinics worldwide [41]. The DoD Military Infectious Dis-
eases Research Program (MIDRP) has a primary mission
of developing vaccine countermeasures to prevent the
major infections, including bacterial diarrhea, encoun-
tered during deployment. Within this sustained research
and development program, surveillance and epidemiolo-
gical research are long-standing components; MIDRP’s
support to the overseas laboratories helps assess the
pathogen-specific burden of disease and the establish-
ment of field sites for interventional studies in military
and host-national pediatric populations. A number of
these efforts are designed for sustainment of activity
(RSN, IEIP, MIDRP, FoodNet, NARMS, GSN) while
some have only been recently established (CHOLDInet,
MAL-ED), and others are likely time-limited (GEMS,
MAL-ED). It is within this context that the AFHSC-
GEIS mission to strengthen the surveillance and
response capabilities of the United States to infectious
diseases that threaten to global public health and mili-
tary readiness should be considered.
Strengths, weaknesses, opportunities and threats
The strengths of the current AFHSC-GEIS system
include its extensive laboratory infrastructure and tech-
nically proficient personnel (Figure 1). Furthermore, the
current surveillance activities are leveraged not only by
other AFHSC-GEIS initiatives but also by other DoD
programs (e.g., MIDRP) with related missions such as
field epidemiology and diagnostic test evaluation.
Alongside these strengths, there are also important
weaknesses. Whereas some laboratories have principal
investigators with special expertise in enteric disease
epidemiology, this is not universal across the entire
AFHSC-GEIS network. An overall lack of strategic gui-
dance within the enteric diseases program was found in
a program review nearly a decade ago [42]. The overseas
laboratories are quite diverse and have had considerable
latitude for the past decade in study design and the tar-
get surveillance populations. This has resulted in varied
and successful studies but also in a system with a lim-
ited ability to compare data across regions.
This diverse network could be strengthened with an
alternative system that uses standardized case defini-
tions, eligibility criteria, basic demographic and clinical
data, and advanced pathogen characterization including
antimicrobial resistance testing. Such an approach could
continue to meet individual laboratory missions while
increasing the quality of study design, with the goal of
being able to generalize findings across populations and
over time. Eventually, the AFHSC-GEIS network could
develop into an integrated platform for multi-center stu-
dies, with emphases to include novel diagnostic testing
and new pathogen discovery.
Other major areas of future interest for AFHSC-GEIS
include the link between acute enteric infections and
chronic sequelae. More than 50 years ago, the initial
descriptions of post-infectious functional bowel disor-
ders were reported [43,44], and two recent systematic
reviews have reported that roughly one out of 10 people
who develop travelers’ diarrhea will go on to acquire
post-infectious irritable bowel syndrome (PI-IBS),
despite normal preexisting bowel habits [45,46]. Though
PI-IBS may not be as debilitating as some other, less
common sequelae of infectious diarrhea such as reactive
arthritis [47], the Guillain-Barre syndrome [48] or
inflammatory bowel disease [49], the attributable burden
of PI-IBS in terms of impact on individual servicemem-
ber health, as well as medical readiness, needs consid-
eration similar to other important long-term impacts of
combat such as traumatic brain injury and posttrau-
matic stress disorder. PI-IBS has been described to per-
sist in 57 percent of patients after six years in one study
and in 76 percent after five years in another [50,51].
T h e s ei l l n e s s e sd e c r e a s et h eq u a l i t yo fl i f eo ft h o s e
afflicted, and the economic impact is considerable [52].
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Surveillance System Lead Institution (s) Description Target
Populations
Year
Established
Rotavirus Surveillance
Networks (RSN)
CDC, WHO Epidemiological support for accelerated rotavirus vaccine
introduction. Five networks have been established aligning
with WHO regional organizations.
Pediatric
populations, global
2000
Cholera and other diarrheal
infection network
(CHOLDInet)
WHO Strengthen laboratory capacity for monitoring and rapid
detection of cholera and other causes of diarrheal diseases
to advance the application of control measures.
Pediatric
populations,
developing world
2009
International Emerging
Infections Program (IEIP)
CDC Six sites established in Asia (Bangladesh, China, Thailand),
Africa (Egypt, Kenya), Central America (Guatemala) with
various activities related to enteric surveillance including
demographic health surveillance systems and acute
diarrhea surveillance.
Adult and pediatric
populations,
developing world
2001
Global Enteric Multi-Center
Surveillance Study (GEMS)
UM-CVD, BMGF Five-year, multi-center study in Asia (Bangladesh, India,
Pakistan), Africa (Gambia, Kenya, Mali, Mozambique) funded
by the Bill & Melinda Gates Foundation to quantify the
burden and identify the microbiologic etiology of severe
diarrheal disease among children 0-59 months of age living
in developing nations, for the purpose of addressing
limitations of current epidemiology.
Pediatric
populations,
developing world
2006
Network for the Study of
Malnutrition and Enteric
Diseases (MAL-ED)
Foundation for NIH,
Fogarty International
Center, BMGF
Five-year ($30 million), multi-site (eight) project in Africa
(South Africa, Tanzania), Asia (Bangladesh, India, Nepal,
Pakistan), and South America (Brazil, Peru) with aims to
incorporate epidemiology and pathophysiology in a
longitudinal study of children from birth to 24 months, to
better understand pathogen-related undernutrition and
impairment of gut and immune function.
Pediatric
populations,
developing world
2009
Foodborne Disease Active
Surveillance Network
(FoodNet)
CDC, USDA, FDA Multicenter network (10 U.S. sites) with active surveillance
for foodborne diseases and related epidemiologic studies
designed to help public health officials better understand
the epidemiology and burden of foodborne diseases in the
United States and disseminate information that can lead to
improvements in public health practice.
All ages, U.S. 1995
National Antimicrobial
Resistance Monitoring
System (NARMS)
FDA, CDC, USDA Prospective monitoring of the occurrence of antimicrobial
resistance of zoonotic pathogens from human diagnostic
specimens, retail meats and food animals, many of which
are the leading pathogens causing acute enteric illness in
the United States.
All ages, U.S. 1996
GeoSentinal Network (GSN) ISTM, CDC A multi-site network of 48 globally dispersed medicine
clinics on all continents (17 in the United States and 31 in
other countries) with aims of worldwide communication
and data collection network for the surveillance of travel-
related morbidity. The GSN is based on the concept that
these clinics are ideally situated to effectively detect
geographic and temporal trends in morbidity among
travelers, immigrants and refugees.
Adult travelers,
global
1995
Military Infectious Diseases
Research Program (MIDRP)
DoD This is a DoD-mandated research program with the
purpose of developing effective vaccines and other
countermeasures against leading causes of infectious
diarrhea in deployed Army, Navy/Marine Corps, and Air
Force personnel. This research program includes basic
science/discovery efforts, pre-clinical and clinical
development, as well as supporting epidemiological studies
and clinical trials at the DoD overseas laboratories.
U.S. military and
other traveler
populations
1970s
Infectious Diseases Clinical
Research Program (IDCRP)
DoD With a mission of conducting research in clinically
important infectious disease threats to the warfighter and
military community, the IDCRP has established a multi-site
travel medicine prospective study that includes an
epidemiological study of travelers’ diarrhea and its post-
infectious sequelae. The study creates a platform to
conduct interventional and diagnostic studies.
U.S. military and
beneficiary traveler
populations
2006
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domestic foodborne illness is unknown, it is likely large
given the frequency of these illnesses [53]. The impact
of these infections on deployed servicemembers and on
the residents of developing countries, particularly chil-
dren, remain unclear, and their study may provide
AFHSC-GEIS with an important potential avenue of
investigation.
While the strengths and weaknesses of the AFHSC-
GEIS system will factor in the future direction of enteric
surveillance, there are a number of external factors that
m a ya l s oi n f l u e n c et h eu l t i m a t es u r v e i l l a n c es t r a t e g y .
Interest in the area of enteric diseases is growing, with
new private industry and philanthropic interest in devel-
oping vaccines for military and civilian populations
(including diarrhea vaccines). The DoD has placed a
higher-level emphasis on conducting more military-to-
military engagements. If appropriately aligned, these
trends could represent new opportunities and garner
additional external support.
Currently, the DoD funding allocated to enteric dis-
ease surveillance activities is relatively lower than that
allocated to other AFHSC-GEIS disease pillars. Given
the real and ever-present impact of diarrheal diseases
experienced by deployed military troops, and the
appearance of additional burden associated with chronic
disease sequelae of these acute infections, an effort to
re-emphasize the critical importance of understanding
and preventing these infections is needed. In recent
years, the enteric disease research and epidemiological
landscape has changed significantly with the establish-
ment of GEMS, MAL-ED, and CDC IEIP sites as pre-
viously mentioned. These multinational well-funded
initiatives may be seen as overlapping with many
AFHSC-GEIS activities. A strategic assessment is needed
to determine the future goals of AFHSC-GEIS, given
limited resources and a potentially constrained fiscal
environment.
Future vision
The knowledge gained through studies of deployed mili-
tary populations has directly contributed to our under-
standing of acute enteric infections and their burden
among military personnel and families stationed in
Strengths
Opportunities
Weaknesses
Threats
Helpful toachievingthemission Harmful toachievingthemission
Internal
attributes
ofthe
DoDͲGEIS
system
External
attributes
ofthe
DoDͲGEIS
system
• Growinginterestinenteric
surveillanceeffortsduetoglobal
vaccineinitiativesandindustry
interest
• IncreasedinterestonmilitaryͲtoͲ
militarycollaborations
• EstablishmentofanEnteric
SurveillanceSteeringCommittee
tofocusandsupportefforts
• Relativelylowemphasis
(funding)comparedtoother
majorsurveillancefoci
• Developmentofother
surveillanceactivitieswith
duplicativegoals
• Highturnoverofinvestigators
• Stateoftheartlaboratoriesand
informationinfrastructure
• Technicallyproficientand
trainedpersonnel
• Representativegeographic
locationsofoperations
• OtherDoD programswith
similarmission(e.g.,MIDRP)
• Lackofadequatestaffpossessing
specificentericdiseaseexpertise
• Lackofguidance,standardization
andcoordinationofefforts
• Cultural&politicalneedfor
maintenanceofindependencein
researchactivity
• Incompleteanalysisofdata
Figure 1 Strength, Weakness, Opportunities and Threats Analysis Matrix for a AFHSC-GEIS Enteric Surveillance Network.
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Page 7 of 11high-risk areas overseas [9,54,55]. To meet the needs
and mission of the DoD and the global public health
community, many of the traditional beliefs about the
preferred types of surveillance activities may need
re-evaluation. For example, the value of year-to-year
tracking of antimicrobial drug resistance among enteric
pathogens needs to be assessed. While it is true that
resistance to enteropathogens may complicate the ther-
apy of diarrhea, most of these infections currently
go untreated and generally are self-limited in nature
[56]. A surveillance strategy is needed that considers the
scope, frequency of assessment, target populations and
regions of interest.
While surveillance among U.S. military and adult tra-
veler populations may be considered ideally aligned with
the AFHSC-GEIS mission, there are challenges in con-
sistent availability of these populations. Often it is
attractive to perform regional surveillance among local
populations as a surrogate for understanding disease
burden and risks; however, the data collected from these
efforts, specifically related to enteric diseases, are not
able to be generalized to deployed U.S. military or adult
traveler populations in the region. Secondary benefits in
conducting studies among local populations include
capacity building and improved host nation relations.
While children in developing countries may serve as
good surrogates in terms of immune naïveté, there may
be important differences in pathogen exposure, environ-
ment, host-response and risk behavior that may impact
the direct generalization of risk to U.S. military popula-
tions. For example, among studies conducted by
NAMRU-3 in deployed military personnel participating
in Operation Bright Star exercises in Egypt, the common
enterotoxigenic E. coli toxin phenotypes were heat-labile
toxin (LT) 17 percent, heat-stable toxin (ST) 56 percent,
and LTST 26 percent; and predominant colonization
factor prevalences were CS6 (32 percent), CS3 (8 per-
cent), and CFA/1 (5 percent) [16-18,22,57]. This is in
contrast to studies among Egyptian pediatric popula-
t i o n sl e s st h a nf i v ey e a r so fa g ei nE g y p t ,w h e r et h e
toxin prevalence (LT 36 percent; ST 51 percent; LTST
12 percent) and colonization factor profiles (CS6 9 per-
cent; CS3 0.6 percent; CFA/1 8 percent) were quite dif-
ferent [10,58-61]. The implications of the varied
prevalence of ETEC strain phenotypes in two different
populations with disease from the same region is criti-
cally important, not only in design considerations of
current ETEC vaccines under development by the DoD,
but also in the selection of appropriate surveillance
populations. Furthermore, while host nation military
personnel may seem to be a surrogate target population,
the acceptability of surveillance in these populations is
complicated by their higher probability of acquired
immunity to many pathogens, an often-high prevalence
of chronic parasite carriage, and potential sensitivities in
collaborating with an institution that may not have a
broadly favorable reputation within the country. None-
theless, given limited DoD funding and resources, the
value of which target populations are best matched for
which objective under an AFHSC-GEIS mission needs
further consideration.
The leadership at AFHSC-GEIS has recognized the
importance of this assessment and the need for refine-
ment of this program and has established the charter of
an Enteric Surveillance Steering Committee (ESSC) to
guide the current laboratory network into the future.
The development of a true network—implying coordina-
tion and standardization in a broader context—would
add significantly to the value and achievement of the
AFHSC-GEIS mission. However, a cautious approach is
needed because each laboratory has variable expertise,
available populations and interests. Strategies to achieve
a coordinated network could range from providing gui-
dance on laboratory methodology to a common core
data element which could be collected on all case
patients enrolled in the various studies (e.g., similar to
what is done with FoodNet reporting sites) to run global
and longitudinal analyses. While comprehensive standar-
dized protocols (e.g., similar to RSN) might be difficult
to implement in today’s landscape, certain aspects
including microbiological methods, antimicrobial resis-
tance testing and clinical data capture could be harmo-
nized across surveillance protocols at each of the sites.
The relatively low funding for enteric disease surveil-
lance compared to other disease pillars needs to be
addressed. Given the real and ever-present impact of
diarrheal diseases experienced by local populations and
deployed military troops, the critical importance of
enteric infections needs to be re-emphasized. This
i m p o r t a n c e ,a sw e l la si d e n t i f i e dg a p st h a tc a nb ef i l l e d ,
should be met with dedicated programmatic funding
allocated to enteric research.
Conclusion
A review of AFHSC-GEIS global enteric surveillance
efforts for the most recent fiscal year (2009) shows a
diverse network needing refinements in vision and stan-
dardization, and a strategically directed surveillance
effort. Recent changes in the global enteric disease sur-
veillance and research landscape provide the necessary
impetus. The strengths of the DoD laboratory network
and individual investigators have generated a number of
positive contributions including: longitudinal data on
emerging antimicrobial resistance; expansive surveillance
activities in multiple countries in practically all regions
of the globe; the important threat information been
obtained from direct study of deployed populations in
Iraq and Afghanistan; the capability of supporting
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Page 8 of 11outbreak response throughout the world in both military
and non-military populations; and the intangible benefits
through medical diplomacy. The challenges in executing
networked studies with operational significance in U.S.
military populations include initiating multi-center sur-
veillance protocols in new host countries with varying
regulatory requirements, and the shifting allocation of
resources and emphasis away from enteric diseases to
other concurrent public health treats (such as with avian
influenza/pandemic influenza). However, these chal-
lenges are countered by the benefit of achieving a true
global network of laboratories aligned in mission and
outcome in mitigating the enteric disease threat.
Future efforts in enteric disease surveillance by
AFHSC-GEIS will be shaped by its newly established
ESSC. As recommended in a prior AFHSC-GEIS pro-
gram review [42] and explored in this landscape analy-
sis, areas for direction include: (1) provision of specific
guidance to laboratories regarding the goals of AFHSC-
GEIS and the qualities that AFHSC-GEIS projects are
expected to possess, in addition to active assistance of
laboratories in developing project plans and periodic
scientific guidance for projects under way; (2) a mechan-
ism for structured project review that permits adequate
time for project conduct between reviews, results in
timely feedback to investigators and is carried out by a
diverse panel of experts; (3) consistent interaction with
staff directing AFHSC-GEIS projects to monitor project
progress, potential for collaboration and needs for assis-
tance; and (4) an improved means of collecting and dis-
tributing surveillance data and other information in a
timely manner.
These recommendations will guide the focus of the
newly chartered ESSC as its members identify strategic
issues, develop new goals, create implementation plans
and evaluate future progress. The task that lies ahead
for the ESSC is to answer the questions of “What do we
do?”, “F o rw h o md ow ed oi t ? ”,a n d“How can we do it
well?” The enhanced coordination and improved scienti-
fic review possibilities of the ESSC will help AFHSC-
GEIS build upon its past successes in enteric disease
surveillance, continuing to take advantage of the DoD
laboratories’ history, experience and global reach to
answer these questions and achieve the AFHSC-GEIS
mission.
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